TY - JOUR
T1 - Inoperable chronic thromboembolic pulmonary hypertension
T2 - Evolution of prognosis over 10 years of new emerging therapies
AU - Staal, Diederik P
AU - Hendriks, Paul M
AU - van Thor, Mitch C J
AU - van de Groep, Liza D
AU - van den Toorn, Leon M
AU - Mulder, Berend-Jan M
AU - Chandoesing, Prewesh P
AU - Kauling, Robert M
AU - Boerman, Sanne
AU - van den Bosch, Annemien E
AU - Mager, Johannes J
AU - Boomars, Karin A
AU - Post, Martijn C
N1 - Publisher Copyright:
© 2024 The Author(s). Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute.
PY - 2024/7
Y1 - 2024/7
N2 - Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.
AB - Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.
KW - chronic thromboembolic pulmonary hypertension
KW - prognosis
KW - pulmonary embolism
KW - pulmonary hypertension
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85201663847&partnerID=8YFLogxK
U2 - 10.1002/pul2.12419
DO - 10.1002/pul2.12419
M3 - Letter
C2 - 39175520
SN - 2045-8932
VL - 14
JO - Pulmonary Circulation
JF - Pulmonary Circulation
IS - 3
M1 - e12419
ER -